180 related articles for article (PubMed ID: 33469111)
1. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease.
Martín-Nares E; Saavedra-González V; Fagundo-Sierra R; Santinelli-Núñez BE; Romero-Maceda T; Calderón-Vasquez K; Hernandez-Molina G
Sci Rep; 2021 Jan; 11(1):1832. PubMed ID: 33469111
[TBL] [Abstract][Full Text] [Related]
2. Serum free light chain assessment in type 1 autoimmune pancreatitis.
Ikemune M; Uchida K; Tsukuda S; Ito T; Nakamaru K; Tomiyama T; Ikeura T; Naganuma M; Okazaki K
Pancreatology; 2021 Apr; 21(3):658-665. PubMed ID: 33741268
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes.
Lanzillotta M; Campochiaro C; Mancuso G; Ramirez GA; Capurso G; Falconi M; Dagna L; Della-Torre E
Rheumatology (Oxford); 2020 Sep; 59(9):2435-2442. PubMed ID: 32591828
[TBL] [Abstract][Full Text] [Related]
4. Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype.
Scarpa R; Pulvirenti F; Pecoraro A; Vultaggio A; Marasco C; Ria R; Altinier S; Compagno N; Firinu D; Plebani M; De Carli M; Matucci A; Vianello F; Vacca A; Spadaro G; Quinti I; Agostini C; Milito C; Cinetto F
Front Immunol; 2020; 11():319. PubMed ID: 32296413
[TBL] [Abstract][Full Text] [Related]
5. The association of serum-free light-chain levels with markers of renal function.
Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
[TBL] [Abstract][Full Text] [Related]
6. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts.
Wallace ZS; Zhang Y; Perugino CA; Naden R; Choi HK; Stone JH;
Ann Rheum Dis; 2019 Mar; 78(3):406-412. PubMed ID: 30612117
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients.
An W; Wu Z; Li M; Yu H; Zhao X; Wang X; Wang Y; Wang Q; Duan W; Kong Y; Ma H; Ou X; You H; Liu Y; Li P; Duan T; Jia J
Orphanet J Rare Dis; 2022 Aug; 17(1):307. PubMed ID: 35927746
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort.
Vikse J; Midtvedt Ø; Fevang BS; Garen T; Palm Ø; Wallenius M; Bakland G; Norheim KB; Molberg Ø; Hoffmann-Vold AM
Arthritis Res Ther; 2023 Sep; 25(1):163. PubMed ID: 37670401
[TBL] [Abstract][Full Text] [Related]
9. Significance of high serum IgG4 in complete or non-full-fledged IgG4-related disease-a retrospective investigation of 845 patients and its clinical relevance.
Tsai HC; Tung HY; Liu CW; Su CF; Sun YS; Chen WS; Chen MH; Lai CC; Liao HT; Yang YY; Huang YH; Tsai CY
Clin Rheumatol; 2022 Jan; 41(1):115-122. PubMed ID: 34455508
[TBL] [Abstract][Full Text] [Related]
10. Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.
Fernández-Codina A; Pinilla B; Pinal-Fernández I; López C; Fraile-Rodríguez G; Fonseca-Aizpuru E; Carballo I; Brito-Zerón P; Feijóo-Massó C; López-Dupla M; Cid MC; Martínez-Valle F; ; ;
Joint Bone Spine; 2018 Dec; 85(6):721-726. PubMed ID: 29452298
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
[TBL] [Abstract][Full Text] [Related]
12. [The clinical characteristics of 346 patients with IgG
Zhang PP; Zhao JZ; Wang M; Feng RE; Liu XW; Lai XM; Li XJ; Zeng JG; Shi HJ; Zhu HD; Xue W; Zhang H; Chen YY; Fei LY; Peng XF; Zeng FC; Zhang YM; Zhang W
Zhonghua Nei Ke Za Zhi; 2017 Sep; 56(9):644-649. PubMed ID: 28870031
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.
Zhang P; Gong Y; Liu Z; Liu Y; Lin W; Li J; Wang M; Liu X; Fei Y; Chen H; Peng L; Li J; Zhou J; Shi Q; Zhang X; Shen M; Zeng X; Zhang F; Li Y; Zhao Y; Zhang W
Int J Rheum Dis; 2019 Aug; 22(8):1479-1488. PubMed ID: 31245907
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease.
Phaopraphat K; Ngamjanyaporn P; Narongroeknawin P; Kasitanon N; Katchamart W
Int J Rheum Dis; 2020 Nov; 23(11):1468-1473. PubMed ID: 32808722
[TBL] [Abstract][Full Text] [Related]
15. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T
J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709
[TBL] [Abstract][Full Text] [Related]
16. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma].
Zhao D; Jiang JQ; Lin L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375
[TBL] [Abstract][Full Text] [Related]
17. Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy.
Wang M; Zhang P; Lin W; Fei Y; Chen H; Li J; Zhang L; Zheng W; Li Y; Zeng X; Zhou J; Lai Y; Liu X; Xue H; Cui Y; Zhou L; Zhao J; Zhang W
Arthritis Res Ther; 2019 Feb; 21(1):44. PubMed ID: 30709411
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus has immunosuppressive effects on heavy/light chain pairs and free light chains in patients after heart transplantation: A relationship with infection.
Lavríková P; Sečník P; Kubíček Z; Jabor A; Hošková L; Franeková J
Transpl Immunol; 2018 Oct; 50():43-47. PubMed ID: 29913223
[TBL] [Abstract][Full Text] [Related]
19. Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease.
Kawashiri SY; Origuchi T; Umeda M; Nishino A; Shimizu T; Fukui S; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Maeda T; Kawano M; Yamamoto M; Izumi Y; Kawakami A
Arthritis Res Ther; 2018 Dec; 20(1):277. PubMed ID: 30547825
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease.
Liu Y; Zhang Y; Bian W; Fu J; Sun X; Chen D; Chen J; Zhao X; Li Y; Zhang W; Li Z
Clin Rheumatol; 2020 Feb; 39(2):491-497. PubMed ID: 31848912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
